P

PainReform Ltd

D
PRFX
USD
0.0721
(13.9216%)
Market Closed
1,200.00
Volume
-33.9
EPS
-
Div Yield
-0.016015
P/E
1,313,606.68
Market Cap
Today
13.9216%
1 Week
15.686%
1 Month
-11.145%
6 Months
-88.373%
12 Months
-95.953%
Year To Date
-96.476%
All Time
0%

Title:
PainReform Ltd

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Do you need help or have a question?